Heart attack deaths are way down—other risks have skyrocketed | Private equity & heart failure | New leadership

Researchers explored more than 52 years of data, highlighting several key trends in the Journal of the American Heart Association.

Overall, 30-day outcomes were not significantly different for hospitals after being acquired by a private equity firm. However, the study’s authors did identify trends that suggest there may be a drop in the quality of care. 

Kenneth Margulies, MD, will be the group's next president. These new terms all begin after the HFSA Annual Scientific Meeting in September.

The first 250 patients has been enrolled in the CORCINCH-HF U.S. pivotal trial evaluating the AccuCinch Transcatheter Left Ventricular Restoration System in patients with HFrEF.

The device was built as a bridge to transplant for patients with end-stage heart failure. It is made of titanium and approximately the size of an adult’s fist.

Researchers tracked short- and long-term data from nearly 2,000 patients, presenting their findings in JACC: Heart Failure. 

Even seeing a cardiologist once per year can help these patients elevate their long-term survival. Many stay home, however, missing out on potentially life-saving guidance and/or treatment.